3 Einträge gefunden

1. German Adjuvant Intergroup Node-positive Study (GAIN):a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients

   1. Möbus, V
   2. von Minckwitz, G
   3. Jackisch, C
   4. Lück, H-J
   5. Schneeweiss, A
   6. Tesch, H
   7. Elling, D

   2017 - Forschungsinformationssystem des UKE
2. PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer--results at the time of surgery.

   1. Untch, M
   2. Fasching, P A
   3. Konecny, G E
   4. von Koch, F
   5. Conrad, U
   6. Fett, W
   7. Kurzeder, C

   2011 - Forschungsinformationssystem des UKE
3. PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer--outcome on prognosis.

   1. Untch, M
   2. von Minckwitz, G
   3. Konecny, G E
   4. Conrad, U
   5. Fett, W
   6. Kurzeder, C
   7. Lück, H-J

   2011 - Forschungsinformationssystem des UKE